Literature DB >> 35976488

Aß Pathology and Neuron-Glia Interactions: A Synaptocentric View.

Christiaan F M Huffels1, Jinte Middeldorp1,2, Elly M Hol3.   

Abstract

Alzheimer's disease (AD) causes the majority of dementia cases worldwide. Early pathological hallmarks include the accumulation of amyloid-ß (Aß) and activation of both astrocytes and microglia. Neurons form the building blocks of the central nervous system, and astrocytes and microglia provide essential input for its healthy functioning. Their function integrates at the level of the synapse, which is therefore sometimes referred to as the "quad-partite synapse". Increasing evidence puts AD forward as a disease of the synapse, where pre- and postsynaptic processes, as well as astrocyte and microglia functioning progressively deteriorate. Here, we aim to review the current knowledge on how Aß accumulation functionally affects the individual components of the quad-partite synapse. We highlight a selection of processes that are essential to the healthy functioning of the neuronal synapse, including presynaptic neurotransmitter release and postsynaptic receptor functioning. We further discuss how Aß affects the astrocyte's capacity to recycle neurotransmitters, release gliotransmitters, and maintain ion homeostasis. We additionally review literature on how Aß changes the immunoprotective function of microglia during AD progression and conclude by summarizing our main findings and highlighting the challenges in current studies, as well as the need for further research.
© 2022. The Author(s).

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-ß; Astrocyte; Glia; Microglia; Synapse

Year:  2022        PMID: 35976488     DOI: 10.1007/s11064-022-03699-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  245 in total

1.  Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein.

Authors:  G R Dawson; G R Seabrook; H Zheng; D W Smith; S Graham; G O'Dowd; B J Bowery; S Boyce; M E Trumbauer; H Y Chen; L H Van der Ploeg; D J Sirinathsinghji
Journal:  Neuroscience       Date:  1999-04       Impact factor: 3.590

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein.

Authors:  G R Seabrook; D W Smith; B J Bowery; A Easter; T Reynolds; S M Fitzjohn; R A Morton; H Zheng; G R Dawson; D J Sirinathsinghji; C H Davies; G L Collingridge; R G Hill
Journal:  Neuropharmacology       Date:  1999-03       Impact factor: 5.250

Review 4.  Alzheimer's disease.

Authors:  C A Lane; J Hardy; J M Schott
Journal:  Eur J Neurol       Date:  2017-10-19       Impact factor: 6.089

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

Review 7.  Epigenetics in Parkinson's and Alzheimer's diseases.

Authors:  Sueli Marques; Tiago Fleming Outeiro
Journal:  Subcell Biochem       Date:  2013

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  The amyloid precursor protein: beyond amyloid.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2006-07-03       Impact factor: 14.195

Review 10.  APP mouse models for Alzheimer's disease preclinical studies.

Authors:  Hiroki Sasaguri; Per Nilsson; Shoko Hashimoto; Kenichi Nagata; Takashi Saito; Bart De Strooper; John Hardy; Robert Vassar; Bengt Winblad; Takaomi C Saido
Journal:  EMBO J       Date:  2017-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.